North America Early Toxicity Testing Market

1      INTRODUCTION

           1.1      REPORT DESCRIPTION

           1.2      RESEARCH METHODOLOGY

                         1.2.1      SECONDARY RESEARCH

                         1.2.2      DATA ANALYSIS FRAMEWORK

                         1.2.3      MARKET SIZE ESTIMATION

                         1.2.4      FORECASTING

                         1.2.5      PRIMARY RESEARCH AND DATA VALIDATION

2      NORTH AMERICA EARLY TOXICITY TESTING MARKET BY TECHNIQUE

           2.1      OVERVIEW

           2.2      IN VIVO

                         2.2.1      IN VIVO MARKET, BY COUNTRY

           2.3      IN VITRO

                         2.3.1      IN VITRO MARKET, BY TECHNIQUE

                                          2.3.1.1      CELL CULTURE MARKET, BY COUNTRY

                                          2.3.1.2      PCR MARKET, BY COUNTRY

                                          2.3.1.3      ELISA MARKET, BY COUNTRY

                                          2.3.1.4      WESTERN BLOTTING MARKET, BY COUNTRY

                                          2.3.1.5      PROTEIN BINDING ASSAYS  MARKET, BY COUNTRY

                         2.3.2      IN VITRO MARKET, BY COUNTRY

           2.4      IN SILICO

                         2.4.1      IN SILICO MARKET, BY COUNTRY

3      NORTH AMERICA EARLY TOXICITY TESTING MARKET BY TOXICITY ENDPOINT

           3.1      OVERVIEW

           3.2      GENOTOXICITY

                         3.2.1      GENOTOXICITY MARKET, BY COUNTRY

           3.3      DERMAL TOXICITY

                         3.3.1      DERMAL TOXICITY MARKET, BY COUNTRY

           3.4      SKIN TOXICITY

                         3.4.1      SKIN TOXICITY MARKET, BY COUNTRY

           3.5      OCULAR TOXICITY

                         3.5.1      OCULAR TOXICITY MARKET, BY COUNTRY

           3.6      PHOTOTOXICITY

                         3.6.1      PHOTOTOXICITY MARKET, BY COUNTRY

           3.7      OTHERS

                         3.7.1      OTHERS MARKET, BY COUNTRY

4      NORTH AMERICA EARLY TOXICITY TESTING MARKET BY END USER

           4.1      OVERVIEW

           4.2      PHARMACEUTICAL INDUSTRY

                         4.2.1      PHARMACEUTICAL INDUSTRY MARKET, BY COUNTRY

           4.3      COSMETIC INDUSTRY

                         4.3.1      COSMETIC INDUSTRY MARKET, BY COUNTRY

           4.4      CHEMICAL INDUSTRY

                         4.4.1      CHEMICAL INDUSTRY MARKET, BY COUNTRY

           4.5      FOOD INDUSTRY

                         4.5.1      FOOD INDUSTRY MARKET, BY COUNTRY

           4.6      OTHERS

                         4.6.1      OTHERS MARKET, BY COUNTRY

5      NORTH AMERICA EARLY TOXICITY TESTING MARKET, BY COUNTRY

           5.1     OVERVIEW

           5.2     UNITED STATES

                         5.2.1     NORTH AMERICA EARLY TOXICITY TESTING MARKET, BY TECHNIQUE

                         5.2.2     NORTH AMERICA EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINT

                         5.2.3     NORTH AMERICA EARLY TOXICITY TESTING MARKET, BY END USER

           5.3     CANADA

                         5.3.1     NORTH AMERICA EARLY TOXICITY TESTING MARKET, BY TECHNIQUE

                         5.3.2     NORTH AMERICA EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINT

                         5.3.3     NORTH AMERICA EARLY TOXICITY TESTING MARKET, BY END USER

           5.4     MEXICO

                         5.4.1     NORTH AMERICA EARLY TOXICITY TESTING MARKET, BY TECHNIQUE

                         5.4.2     NORTH AMERICA EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINT

                         5.4.3     NORTH AMERICA EARLY TOXICITY TESTING MARKET, BY END USER

6      COMPANY PROFILES

           6.1   INOTIV INC.

                         6.1.1   COMPANY OVERVIEW

                         6.1.2   COMPANY SNAPSHOT

                         6.1.3   OPERATING BUSINESS SEGMENTS

                         6.1.4   PRODUCT PORTFOLIO

                         6.1.5   BUSINESS PERFORMANCE

                         6.1.6   BUSINESS SEGMENTS

                         6.1.7   GEOGRAPHIC SEGMENTS

                         6.1.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         6.1.9   PRIMARY MARKET COMPETITORS

           6.2   BIO-RAD LABORATORIES INC.

                         6.2.1   COMPANY OVERVIEW

                         6.2.2   COMPANY SNAPSHOT

                         6.2.3   OPERATING BUSINESS SEGMENTS

                         6.2.4   PRODUCT PORTFOLIO

                         6.2.5   BUSINESS PERFORMANCE

                         6.2.6   BUSINESS SEGMENTS

                         6.2.7   GEOGRAPHIC SEGMENTS

                         6.2.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         6.2.9   PRIMARY MARKET COMPETITORS

           6.3   EVOTEC A.G.

                         6.3.1   COMPANY OVERVIEW

                         6.3.2   COMPANY SNAPSHOT

                         6.3.3   OPERATING BUSINESS SEGMENTS

                         6.3.4   PRODUCT PORTFOLIO

                         6.3.5   BUSINESS PERFORMANCE

                         6.3.6   BUSINESS SEGMENTS

                         6.3.7   GEOGRAPHIC SEGMENTS

                         6.3.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         6.3.9   PRIMARY MARKET COMPETITORS

           6.4   AGILENT TECHNOLOGIES INC.

                         6.4.1   COMPANY OVERVIEW

                         6.4.2   COMPANY SNAPSHOT

                         6.4.3   OPERATING BUSINESS SEGMENTS

                         6.4.4   PRODUCT PORTFOLIO

                         6.4.5   BUSINESS PERFORMANCE

                         6.4.6   BUSINESS SEGMENTS

                         6.4.7   GEOGRAPHIC SEGMENTS

                         6.4.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         6.4.9   PRIMARY MARKET COMPETITORS

           6.5   WUXI APPTEC

                         6.5.1   COMPANY OVERVIEW

                         6.5.2   COMPANY SNAPSHOT

                         6.5.3   OPERATING BUSINESS SEGMENTS

                         6.5.4   PRODUCT PORTFOLIO

                         6.5.5   BUSINESS PERFORMANCE

                         6.5.6   BUSINESS SEGMENTS

                         6.5.7   GEOGRAPHIC SEGMENTS

                         6.5.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         6.5.9   PRIMARY MARKET COMPETITORS

           6.6   BRUKER

                         6.6.1   COMPANY OVERVIEW

                         6.6.2   COMPANY SNAPSHOT

                         6.6.3   OPERATING BUSINESS SEGMENTS

                         6.6.4   PRODUCT PORTFOLIO

                         6.6.5   BUSINESS PERFORMANCE

                         6.6.6   BUSINESS SEGMENTS

                         6.6.7   GEOGRAPHIC SEGMENTS

                         6.6.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         6.6.9   PRIMARY MARKET COMPETITORS

           6.7   PERKINELMER INC.

                         6.7.1   COMPANY OVERVIEW

                         6.7.2   COMPANY SNAPSHOT

                         6.7.3   OPERATING BUSINESS SEGMENTS

                         6.7.4   PRODUCT PORTFOLIO

                         6.7.5   BUSINESS PERFORMANCE

                         6.7.6   BUSINESS SEGMENTS

                         6.7.7   GEOGRAPHIC SEGMENTS

                         6.7.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         6.7.9   PRIMARY MARKET COMPETITORS

           6.8   ENZO BIOCHEM INC.

                         6.8.1   COMPANY OVERVIEW

                         6.8.2   COMPANY SNAPSHOT

                         6.8.3   OPERATING BUSINESS SEGMENTS

                         6.8.4   PRODUCT PORTFOLIO

                         6.8.5   BUSINESS PERFORMANCE

                         6.8.6   BUSINESS SEGMENTS

                         6.8.7   GEOGRAPHIC SEGMENTS

                         6.8.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         6.8.9   PRIMARY MARKET COMPETITORS

           6.9   DANAHER CORPORATION

                         6.9.1   COMPANY OVERVIEW

                         6.9.2   COMPANY SNAPSHOT

                         6.9.3   OPERATING BUSINESS SEGMENTS

                         6.9.4   PRODUCT PORTFOLIO

                         6.9.5   BUSINESS PERFORMANCE

                         6.9.6   BUSINESS SEGMENTS

                         6.9.7   GEOGRAPHIC SEGMENTS

                         6.9.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         6.9.9   PRIMARY MARKET COMPETITORS

           6.10   EUROFINS SCIENTIFIC SE

                         6.10.1   COMPANY OVERVIEW

                         6.10.2   COMPANY SNAPSHOT

                         6.10.3   OPERATING BUSINESS SEGMENTS

                         6.10.4   PRODUCT PORTFOLIO

                         6.10.5   BUSINESS PERFORMANCE

                         6.10.6   BUSINESS SEGMENTS

                         6.10.7   GEOGRAPHIC SEGMENTS

                         6.10.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         6.10.9   PRIMARY MARKET COMPETITORS

           6.11   CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

                         6.11.1   COMPANY OVERVIEW

                         6.11.2   COMPANY SNAPSHOT

                         6.11.3   OPERATING BUSINESS SEGMENTS

                         6.11.4   PRODUCT PORTFOLIO

                         6.11.5   BUSINESS PERFORMANCE

                         6.11.6   BUSINESS SEGMENTS

                         6.11.7   GEOGRAPHIC SEGMENTS

                         6.11.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         6.11.9   PRIMARY MARKET COMPETITORS

           6.12   LABCORP DRUG DEVELOPMENT.

                         6.12.1   COMPANY OVERVIEW

                         6.12.2   COMPANY SNAPSHOT

                         6.12.3   OPERATING BUSINESS SEGMENTS

                         6.12.4   PRODUCT PORTFOLIO

                         6.12.5   BUSINESS PERFORMANCE

                         6.12.6   BUSINESS SEGMENTS

                         6.12.7   GEOGRAPHIC SEGMENTS

                         6.12.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         6.12.9   PRIMARY MARKET COMPETITORS

           6.13   PROMEGA CORPORATION

                         6.13.1   COMPANY OVERVIEW

                         6.13.2   COMPANY SNAPSHOT

                         6.13.3   OPERATING BUSINESS SEGMENTS

                         6.13.4   PRODUCT PORTFOLIO

                         6.13.5   BUSINESS PERFORMANCE

                         6.13.6   BUSINESS SEGMENTS

                         6.13.7   GEOGRAPHIC SEGMENTS

                         6.13.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         6.13.9   PRIMARY MARKET COMPETITORS

           6.14   INSPHERO AG

                         6.14.1   COMPANY OVERVIEW

                         6.14.2   COMPANY SNAPSHOT

                         6.14.3   OPERATING BUSINESS SEGMENTS

                         6.14.4   PRODUCT PORTFOLIO

                         6.14.5   BUSINESS PERFORMANCE

                         6.14.6   BUSINESS SEGMENTS

                         6.14.7   GEOGRAPHIC SEGMENTS

                         6.14.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         6.14.9   PRIMARY MARKET COMPETITORS

           6.15   THERMO FISHER SCIENTIFIC INC.

                         6.15.1   COMPANY OVERVIEW

                         6.15.2   COMPANY SNAPSHOT

                         6.15.3   OPERATING BUSINESS SEGMENTS

                         6.15.4   PRODUCT PORTFOLIO

                         6.15.5   BUSINESS PERFORMANCE

                         6.15.6   BUSINESS SEGMENTS

                         6.15.7   GEOGRAPHIC SEGMENTS

                         6.15.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         6.15.9   PRIMARY MARKET COMPETITORS

LIST OF TABLES

TABLE 1. NORTH AMERICA EARLY TOXICITY TESTING MARKET, BY TECHNIQUE, 2022-2030, MILLION USD

TABLE 2. NORTH AMERICA IN VITRO MARKET, BY TECHNIQUE, 2022-2030, MILLION USD

TABLE 3. NORTH AMERICA EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINTS, 2022-2030, MILLION USD

TABLE 4. NORTH AMERICA EARLY TOXICITY TESTING MARKET, BY END USER, 2022-2030, MILLION USD

TABLE 5. NORTH AMERICA EARLY TOXICITY TESTING MARKET, BY COUNTRY, 2022-2030, MILLION USD

TABLE 6. U.S. EARLY TOXICITY TESTING MARKET, BY TECHNIQUE, 2022-2030, MILLION USD

TABLE 7. U.S. IN VITRO MARKET, BY TECHNIQUE, 2022-2030, MILLION USD

TABLE 8. U.S. EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINTS, 2022-2030, MILLION USD

TABLE 9. U.S. EARLY TOXICITY TESTING MARKET, BY END USER, 2022-2030, MILLION USD

TABLE 10. CANADA EARLY TOXICITY TESTING MARKET, BY TECHNIQUE, 2022-2030, MILLION USD

TABLE 11. CANADA IN VITRO MARKET, BY TECHNIQUE, 2022-2030, MILLION USD

TABLE 12. CANADA EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINTS, 2022-2030, MILLION USD

TABLE 13. CANADA EARLY TOXICITY TESTING MARKET, BY END USER, 2022-2030, MILLION USD

TABLE 14. MEXICO EARLY TOXICITY TESTING MARKET, BY TECHNIQUE, 2022-2030, MILLION USD

TABLE 15. MEXICO IN VITRO MARKET, BY TECHNIQUE, 2022-2030, MILLION USD

TABLE 16. MEXICO EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINTS, 2022-2030, MILLION USD

TABLE 17. MEXICO EARLY TOXICITY TESTING MARKET, BY END USER, 2022-2030, MILLION USD

TABLE 18. INOTIV INC.: COMPANY SNAPSHOT

TABLE 19. INOTIV INC: OPERATING SEGMENTS

TABLE 20. INOTIV INC.: PR0DUCT PORTFOLIO

TABLE 21. INOTIV INC.: BUSINESS SEGMENT

TABLE 22. INOTIV INC.: GEOGRAPHIC SEGMENT

TABLE 23. INOTIV INC.: KEY STRATEGIC MOVES & DEVELOPMENTS

TABLE 24. BIO-RAD LABORATORIES INC: COMPANY SNAPSHOT

TABLE 25. BIO-RAD LABORATORIES INC: OPERATING SEGMENTS

TABLE 26. BIO-RAD LABORATORIES INC: PRODUCT PORTFOLIO

TABLE 27. BIO-RAD LABORATORIES INC: BUSINESS SEGMENT

TABLE 28. BIO-RAD LABORATORIES INC: GEOGRAPHIC SEGMENT

TABLE 29. BIO-RAD LABORATORIES INC: KEY STRATEGIC MOVES & DEVELOPMENTS

TABLE 30. EVOTEC A.G.: COMPANY SNAPSHOT

TABLE 31. EVOTEC A.G.: OPERATING SEGMENTS

TABLE 32. EVOTEC A.G.: PRODUCT PORTFOLIO

TABLE 33. EVOTEC A.G.: BUSINESS SEGMENT

TABLE 34. EVOTEC A.G.: GEOGRAPHIC SEGMENT

TABLE 35. EVOTEC A.G.: KEY STRATEGIC MOVES & DEVELOPMENTS

TABLE 36. AGILENT TECHNOLOGIES INC: COMPANY SNAPSHOT

TABLE 37. AGILENT TECHNOLOGIES INC: OPERATING SEGMENTS

TABLE 38. AGILENT TECHNOLOGIES INC: PRODUCT PORTFOLIO

TABLE 39. AGILENT TECHNOLOGIES INC: BUSINESS SEGMENT

TABLE 40. AGILENT TECHNOLOGIES INC: GEOGRAPHIC SEGMENT

TABLE 41. AGILENT TECHNOLOGIES INC: KEY STRATEGIC MOVES & DEVELOPMENTS

TABLE 42. WUXI APPTEC.: COMPANY SNAPSHOT

TABLE 43. WUXI APPTEC: OPERATING SEGMENTS

TABLE 44. WUXI APPTEC.: PR0DUCT PORTFOLIO

TABLE 45. WUXI APPTEC.: BUSINESS SEGMENT

TABLE 46. WUXI APPTEC.: GEOGRAPHIC SEGMENT

TABLE 47. WUXI APPTEC.: KEY STRATEGIC MOVES & DEVELOPMENTS

TABLE 48. THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT

TABLE 49. THERMO FISHER SCIENTIFIC: OPERATING SEGMENTS

TABLE 50. THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO

TABLE 51. THERMO FISHER SCIENTIFIC: BUSINESS SEGMENT

TABLE 52. THERMO FISHER SCIENTIFIC: GEOGRAPHIC SEGMENT

TABLE 53. THERMO FISHER SCIENTIFIC INC.: KEY STRATEGIC MOVES & DEVELOPMENTS

TABLE 54. BRUKER: COMPANY SNAPSHOT

TABLE 55. BRUKER: OPERATING SEGMENTS

TABLE 56. BRUKER: PRODUCT PORTFOLIO

TABLE 57. BRUKER: BUSINESS SEGMENT

TABLE 58. BRUKER: GEOGRAPHIC SEGMENT

TABLE 59. BRUKER: KEY STRATEGIC MOVES & DEVELOPMENTS

TABLE 60. PERKINELMER INC.: COMPANY SNAPSHOT

TABLE 61. PERKINELMER INC.: OPERATING SEGMENTS

TABLE 62. PERKINELMER INC.: PRODUCT PORTFOLIO

TABLE 63. PERKINELMER INC.: BUSINESS SEGMENT

TABLE 64. PERKINELMER INC.: GEOGRAPHIC SEGMENT

TABLE 65. PERKINELMER INC.: KEY STRATEGIC MOVES & DEVELOPMENTS

TABLE 66. ENZO BIOCHEM INC.: COMPANY SNAPSHOT

TABLE 67. ENZO BIOCHEM INC.: OPERATING SEGMENTS

TABLE 68. ENZO BIOCHEM INC.: PRODUCT PORTFOLIO

TABLE 69. ENZO BIOCHEM INC.: BUSINESS SEGMENT

TABLE 70. ENZO BIOCHEM INC.: GEOGRAPHIC SEGMENT

TABLE 71. ENZO BIOCHEM INC.: KEY STRATEGIC MOVES & DEVELOPMENTS

TABLE 72. DANAHER CORPORATION: COMPANY SNAPSHOT

TABLE 73. DANAHER CORPORATION: OPERATING SEGMENTS

TABLE 74. DANAHER CORPORATION: PRODUCT PORTFOLIO

TABLE 75. DANAHER CORPORATION: BUSINESS SEGMENT

TABLE 76. DANAHER CORPORATION: KEY STRATEGIC MOVES & DEVELOPMENTS

TABLE 77. EUROFINS SCIENTIFIC SE: COMPANY SNAPSHOT

TABLE 78. EUROFINS SCIENTIFIC SE: PRODUCT PORTFOLIO

TABLE 79. EUROFINS SCIENTIFIC SE: GEOGRAPHIC SEGMENT

TABLE 80. EUROFINS SCIENTIFIC SE: KEY STRATEGIC MOVES & DEVELOPMENTS

TABLE 81. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT

TABLE 82. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: OPERATING SEGMENTS

TABLE 83. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: PRODUCT PORTFOLIO

TABLE 84. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: BUSINESS SEGMENT

TABLE 85. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: GEOGRAPHIC SEGMENT

TABLE 86. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: KEY STRATEGIC MOVES & DEVELOPMENTS

TABLE 87. LABCORP DRUG DEVELOPMENT.: COMPANY SNAPSHOT

TABLE 88. LABCORP DRUG DEVELOPMENT.: OPERATING SEGMENTS

TABLE 89. LABCORP DRUG DEVELOPMENT.: PRODUCT PORTFOLIO

TABLE 90. LABCORP DRUG DEVELOPMENT.: BUSINESS SEGMENT

TABLE 91. LABCORP DRUG DEVELOPMENT.: GEOGRAPHIC SEGMENT

TABLE 92. LABCORP DRUG DEVELOPMENT.: KEY STRATEGIC MOVES & DEVELOPMENTS

TABLE 93. PROMEGA CORPORATION: COMPANY SNAPSHOT

TABLE 94. PROMEGA CORPORATION: PRODUCT PORTFOLIO

TABLE 95. INSPHERO AG: COMPANY SNAPSHOT

TABLE 96. INSPHERO AG: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 1. NORTH AMERICA EARLY TOXICITY TESTING MARKET, BY TECHNIQUE, 2022-2030, MILLION USD

FIGURE 2. NORTH AMERICA IN VITRO MARKET, BY TECHNIQUE, 2022-2030, MILLION USD

FIGURE 3. NORTH AMERICA EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINTS, 2022-2030, MILLION USD

FIGURE 4. NORTH AMERICA EARLY TOXICITY TESTING MARKET, BY END USER, 2022-2030, MILLION USD

FIGURE 5. NORTH AMERICA EARLY TOXICITY TESTING MARKET, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 6. U.S. EARLY TOXICITY TESTING MARKET, BY TECHNIQUE, 2022-2030, MILLION USD

FIGURE 7. U.S. IN VITRO MARKET, BY TECHNIQUE, 2022-2030, MILLION USD

FIGURE 8. U.S. EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINTS, 2022-2030, MILLION USD

FIGURE 9. U.S. EARLY TOXICITY TESTING MARKET, BY END USER, 2022-2030, MILLION USD

FIGURE 10. CANADA EARLY TOXICITY TESTING MARKET, BY TECHNIQUE, 2022-2030, MILLION USD

FIGURE 11. CANADA IN VITRO MARKET, BY TECHNIQUE, 2022-2030, MILLION USD

FIGURE 12. CANADA EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINTS, 2022-2030, MILLION USD

FIGURE 13. CANADA EARLY TOXICITY TESTING MARKET, BY END USER, 2022-2030, MILLION USD

FIGURE 14. MEXICO EARLY TOXICITY TESTING MARKET, BY TECHNIQUE, 2022-2030, MILLION USD

FIGURE 15. MEXICO IN VITRO MARKET, BY TECHNIQUE, 2022-2030, MILLION USD

FIGURE 16. MEXICO EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINTS, 2022-2030, MILLION USD

FIGURE 17. MEXICO EARLY TOXICITY TESTING MARKET, BY END USER, 2022-2030, MILLION USD

FIGURE 18. INOTIV INC.: NET SALES, 2020–2022 ($MILLION)

FIGURE 19. INOTIV INC: PRIMARY MARKET COMPETITORS

FIGURE 20. BIO-RAD LABORATORIES INC CO: NET SALES, 2020–2022 ($MILLION)

FIGURE 21. BIO-RAD LABORATORIES INC: PRIMARY MARKET COMPETITORS

FIGURE 22. EVOTEC A.G.: NET SALES, 2019–2021 ($MILLION)

FIGURE 23. EVOTEC A.G.: PRIMARY MARKET COMPETITORS

FIGURE 24. AGILENT TECHNOLOGIES INC: NET SALES, 2020–2022 ($MILLION)

FIGURE 25. AGILENT TECHNOLOGIES INC: PRIMARY MARKET COMPETITORS

FIGURE 26. WUXI APPTEC.: NET SALES, 2020–2022 ($MILLION)

FIGURE 27. WUXI APPTEC: PRIMARY MARKET COMPETITORS

FIGURE 28. THERMO FISHER SCIENTIFIC: NET SALES, 2019–2021 ($MILLION)

FIGURE 29. THERMO FISHER SCIENTIFIC: PRIMARY MARKET COMPETITORS

FIGURE 30. BRUKER: NET SALES, 2019–2021 ($MILLION)

FIGURE 31. BRUKER: PRIMARY MARKET COMPETITORS

FIGURE 32. PERKINELMER INC.: NET SALES, 2020–2022 ($MILLION)

FIGURE 33. PERKINELMER INC.: PRIMARY MARKET COMPETITORS

FIGURE 34. ENZO BIOCHEM INC.: NET SALES, 2019–2021 ($MILLION)

FIGURE 35. ENZO BIOCHEM INC.: PRIMARY MARKET COMPETITORS

FIGURE 36. DANAHER CORPORATION: NET SALES, 2020–2022 ($MILLION)

FIGURE 37. DANAHER CORPORATION: PRIMARY MARKET COMPETITORS

FIGURE 38. EUROFINS SCIENTIFIC SE CO: NET SALES, 2020–2022 ($MILLION)

FIGURE 39. EUROFINS SCIENTIFIC SE: PRIMARY MARKET COMPETITORS

FIGURE 40. CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CO: NET SALES, 2020–2022 ($MILLION)

FIGURE 41. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: PRIMARY MARKET COMPETITORS

FIGURE 42. LABCORP DRUG DEVELOPMENT. CO: NET SALES, 2020–2022 ($MILLION)

FIGURE 43. LABCORP DRUG DEVELOPMENT.: PRIMARY MARKET COMPETITORS

FIGURE 44. PROMEGA CORPORATION: PRIMARY MARKET COMPETITORS

FIGURE 45. INSPHERO AG: PRIMARY MARKET COMPETITORS

 

At Next Move Strategy Consulting, we understand that insightful market research is the cornerstone of successful business decisions. That's why we employ a robust and multifaceted approach, combining various methodologies to deliver the most accurate and actionable data for our clients.

Research Landscape

We navigate the world of research with two primary approaches:

Qualitative Approach

Our qualitative research methodologies involve immersive techniques such as in-depth interviews, focus groups, and observational studies. By engaging directly with individuals and stakeholders, we uncover valuable insights that quantitative data alone may overlook.

Quantitative Research

In tandem with qualitative methodologies, NMSC leverages the power of Quantitative Research to provide a robust foundation of numerical insights. Through systematic data collection and analysis, we quantify patterns, preferences, and market trends, offering a comprehensive view of the business landscape.

Our quantitative research approach employs diverse tools, including surveys, experiments, and statistical modelling. These methodologies enable us to gather data from a large and representative sample, ensuring the statistical significance of our findings. By employing structured questionnaires and standardized data collection methods, we guarantee the reliability and validity of the information we present to our clients.

Quantitative research is particularly effective in measuring the prevalence of trends, assessing market size, and gauging the impact of various factors on consumer behavior. The numerical precision attained through this approach equips our clients with actionable insights, facilitating data-driven decision-making and strategy formulation.

 

Our Specialized Toolbox for Industry-Specific Market Research

We deploy a specialized arsenal of techniques tailored to meet your unique requirements. Here's a glimpse into our comprehensive toolbox:

Information Procurement

The stage entails acquiring market data or relevant information through various sources and methodologies.

Market Research Approach

We utilize both top-down and bottom-up approaches in market research analysis to achieve a comprehensive understanding of the market dynamics, leveraging the broad perspective of industry trends and macroeconomic factors alongside detailed insights from specific segments and individual companies.

Porters Five Forces Analysis

We conduct Porter's Five Forces analysis to evaluate the competitive landscape of an industry, providing us with insights into factors that affect profitability and strategic positioning.

              

SWOT Analysis

We conduct SWOT analysis to understand market trends, identify potential threats, capitalize on opportunities, and assess our strengths and weaknesses.

Forecasting

We utilize a forecasting model to predict future consumption by considering parameters like population, economics, regulations, market competition, drivers, constraints, technology, and pricing. We also employ statistical techniques such as multilinear regression, exponential smoothing, moving average, ARIMA, and Monte Carlo simulations for accurate predictions. In econometric forecasting, we analyzed short-term and long-term event impacts, attributing values based on regulatory frameworks, economic factors, and market events.